Identification of agents for use in the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/496 (2006.01) A61K 31/132 (2006.01) A61K 31/145 (2006.01) A61K 31/198 (2006.01) A61K 31/405 (2006.01) A61K 31/444 (2006.01) A61K 31/4745 (2006.01) A61P 25/28 (2006.01) A61P 39/06 (2006.01)

Patent

CA 2284170

The invention relates to the identification of pharmacological agents to be used in the treatment of Alzheimer's disease and related pathological conditions. Methods and compositions for treatment of conditions caused by amyloidosis, A.beta.-mediated ROS formation, or both, such as Alzheimer's disease, are disclosed.

Cette invention a pour objet l'identification d'agents pharmacologiques destinés à être utilisés dans le traitement de la maladie d'Alzheimer et des états pathologiques associés. Sont également présentés des procédés et des compositions permettant de traiter des états pathologiques provoqués par l'amylose, la formation d'espèces réactives d'oxygène (EOR) induite par des peptides A beta , ou bien les deux, comme la maladie d'Alzheimer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Identification of agents for use in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Identification of agents for use in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of agents for use in the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1512604

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.